• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 20th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
A nurse prepares to administer a malaria vaccine to an infant at the health center in Datcheka, Cameroon January 22, 2024.
A nurse prepares to administer a malaria vaccine to an infant at the health center in Datcheka, Cameroon January 22, 2024.
Home
Business
Healthcare & Pharmaceuticals

Some malaria, HIV, TB programme cuts reversed by US, groups say

March 6th, 2025 | 13:15 PM BUSINESS Healthcare & Pharmaceuticals 3

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Multistate salmonella infections climb to 431, US CDC says
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder
Michigan confirms human case of rare mosquito-borne disease
US FDA approves Regeneron's rare bone disorder drug
By Aaron Ross, Jennifer Rigby

Some lifesaving health projects that had their U.S. funding contracts abruptly terminated last week have received letters reversing that decision, several of the groups told Reuters.

The aid recipients said the decisions were promising, but that their work remains in limbo as funding for their projects from the world's biggest donor had not yet restarted.

The Trump administration canceled on Thursday around 90% of contracts funded by the U.S. Agency for International Development (USAID) and the U.S. State Department, sending shockwaves across the global aid community.

Michael Adekunle Charles, chief executive of the RBM Partnership to End Malaria, said his organization's letter reversing that decision arrived late Wednesday.

"I think it's good news. We need to wait in the coming days to get additional guidance," he said. "Our priority is saving lives, so the earlier we can get started to continue saving lives the better."

However, Charles said that would be difficult unless funding started to flow again.

Work on the USAID-funded supply chain for malaria drugs, nets and tests could also restart, one contractor was told, but they are still awaiting payment for past invoices.

Some U.S. foreign aid contractors and grant recipients will take their fight to get payments restored to a federal judge in the United States on Thursday.

A U.S. State Department spokesperson said the Trump administration had been working to review every dollar spent "to ensure taxpayer resources are being used to make America safer, stronger, and more prosperous" and had reviewed around 15,600 awards, contracts and grants, but did not respond to questions about why some terminations had been reversed and others not, or on restarting funding.

Other programmes hosted by the U.N. and partly funded by the United States, including the Stop TB Partnership, also had termination notices reversed this week.

"It sounds good but we cannot draw down money ... and we have no clarity," said Lucica Ditiu, executive director of the Stop TB Partnership.

In Kenya, USAID officials told health organisations on Wednesday that terminations of contracts funded by the President's Emergency Plan for AIDS Relief had been rescinded, Nelson Otwoma, the director of a national network for people living with HIV/AIDS, told Reuters.

This means organisations can start lifesaving HIV care and treatment services again, said Otwoma, who attended the meeting in Nairobi.

Kenya's health ministry, which convened Wednesday's meeting, did not immediately respond to a request for comment.

Trump ordered a 90-day pause on all U.S. foreign aid on his first day back in office. The ensuing stop-work orders halted USAID operations around the world and jeopardized the delivery of life-saving food and medical aid, throwing global humanitarian relief efforts into chaos. The administration has also placed most USAID staff on leave and eliminated 1,600 jobs.

Subsequent waivers for some of the work added to the confusion, followed by the terminations last week.

  • Topic
  • USA
  • TRUMP/AID
  • HEALTH (UPDATE 2, PIX)
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Multistate salmonella infections climb to 431, US CDC says

Related Posts

Healthcare & Pharmaceuticals
August 19th, 2026

Multistate salmonella infections climb to 431, US CDC says

Healthcare & Pharmaceuticals
August 19th, 2026

Ultragenyx's gene therapy wins first FDA approval for rare metabolic dis...

Healthcare & Pharmaceuticals
August 19th, 2026

Michigan confirms human case of rare mosquito-borne disease

Healthcare & Pharmaceuticals
August 19th, 2026

US FDA approves Regeneron's rare bone disorder drug

Healthcare & Pharmaceuticals
August 19th, 2026

West Nile virus outbreak kills four in North Macedonia 

Healthcare & Pharmaceuticals
August 19th, 2026

Moderna shares double as cancer vaccine data rekindles investor hopes

The Wire
Aug 20th 3 h ago
Investigates

In China, rocket launches fuel tourism and space-age dreams

Aug 19th 4 h ago
Asia Pacific

Japan exports rise 23.2% year/year in July

Aug 19th 4 h ago
Baseball

D-backs score twice in 10th, salvage series finale at Red S...

Aug 19th 5 h ago
Government

US tells schools not to alter discipline policies to reduce...

Aug 19th 5 h ago
Transactional

China tax crackdown forces wealthy investors to assess thei...

TRENDING ON FINANCETIME
Aug 19th, 2026 Tennis

Paul ousts top seed Zverev to reach Cincinnati quarter-finals

Aug 19th, 2026 Litigation

AIA Group's first-half new business value rises 10%

Aug 19th, 2026 Energy

Brazil's largest thermal power plant shut down after equipment failure

Aug 19th, 2026 United Kingdom

Key moments in Prince Harry and Meghan's six years in California

Aug 19th, 2026 Sports

Orioles reinstate C Samuel Basallo (shoulder) to active roster

Markets-Sectors
ENERGY -0.16%
FINANCIALS -0.62%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT